Effects of phencyclidine in combination with morphine on the levels of met-enkephalin, dopamine, DOPAC and HVA in discrete brain areas of mice

Toshitaka Nabeshima, M. Hiramatsu, H. Furukawa, T. Kameyama

研究成果: Article

5 引用 (Scopus)

抄録

The study investigated the interaction between phencyclidine (PCP) and morphine in affecting the levels of met-enkephalin, dopamine, DOPAC and HVA in mice. Morphine 5 mg/kg alone and PCP 10 mg/kg alone failed to change the levels of met-enkephalin in the midbrain and striatum. However, PCP in combination with morphine produced an increase in met-enkephalin levels and a decrease in HVA levels. In the midbrain, there was a direct relationship between the decrease in met-enkephalin levels and the increase in HVA levels. These results suggest that PCP may change the function in dopaminergic and enkephalinergic neuronal systems in the midbrain and/or striatum.

元の言語English
ページ(範囲)805-809
ページ数5
ジャーナルNeuropharmacology
24
発行部数8
DOI
出版物ステータスPublished - 01-01-1985
外部発表Yes

Fingerprint

3,4-Dihydroxyphenylacetic Acid
Phencyclidine
Methionine Enkephalin
Morphine
Dopamine
Mesencephalon
Brain

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Cellular and Molecular Neuroscience

これを引用

@article{9c60203d24414c52a9b9638a4b223d72,
title = "Effects of phencyclidine in combination with morphine on the levels of met-enkephalin, dopamine, DOPAC and HVA in discrete brain areas of mice",
abstract = "The study investigated the interaction between phencyclidine (PCP) and morphine in affecting the levels of met-enkephalin, dopamine, DOPAC and HVA in mice. Morphine 5 mg/kg alone and PCP 10 mg/kg alone failed to change the levels of met-enkephalin in the midbrain and striatum. However, PCP in combination with morphine produced an increase in met-enkephalin levels and a decrease in HVA levels. In the midbrain, there was a direct relationship between the decrease in met-enkephalin levels and the increase in HVA levels. These results suggest that PCP may change the function in dopaminergic and enkephalinergic neuronal systems in the midbrain and/or striatum.",
author = "Toshitaka Nabeshima and M. Hiramatsu and H. Furukawa and T. Kameyama",
year = "1985",
month = "1",
day = "1",
doi = "10.1016/0028-3908(85)90016-4",
language = "English",
volume = "24",
pages = "805--809",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Limited",
number = "8",

}

TY - JOUR

T1 - Effects of phencyclidine in combination with morphine on the levels of met-enkephalin, dopamine, DOPAC and HVA in discrete brain areas of mice

AU - Nabeshima, Toshitaka

AU - Hiramatsu, M.

AU - Furukawa, H.

AU - Kameyama, T.

PY - 1985/1/1

Y1 - 1985/1/1

N2 - The study investigated the interaction between phencyclidine (PCP) and morphine in affecting the levels of met-enkephalin, dopamine, DOPAC and HVA in mice. Morphine 5 mg/kg alone and PCP 10 mg/kg alone failed to change the levels of met-enkephalin in the midbrain and striatum. However, PCP in combination with morphine produced an increase in met-enkephalin levels and a decrease in HVA levels. In the midbrain, there was a direct relationship between the decrease in met-enkephalin levels and the increase in HVA levels. These results suggest that PCP may change the function in dopaminergic and enkephalinergic neuronal systems in the midbrain and/or striatum.

AB - The study investigated the interaction between phencyclidine (PCP) and morphine in affecting the levels of met-enkephalin, dopamine, DOPAC and HVA in mice. Morphine 5 mg/kg alone and PCP 10 mg/kg alone failed to change the levels of met-enkephalin in the midbrain and striatum. However, PCP in combination with morphine produced an increase in met-enkephalin levels and a decrease in HVA levels. In the midbrain, there was a direct relationship between the decrease in met-enkephalin levels and the increase in HVA levels. These results suggest that PCP may change the function in dopaminergic and enkephalinergic neuronal systems in the midbrain and/or striatum.

UR - http://www.scopus.com/inward/record.url?scp=0021965853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021965853&partnerID=8YFLogxK

U2 - 10.1016/0028-3908(85)90016-4

DO - 10.1016/0028-3908(85)90016-4

M3 - Article

VL - 24

SP - 805

EP - 809

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

IS - 8

ER -